0,973  0,002  Antineoplastic (ovarian cancer)
0,961  0,004  Apoptosis agonist
0,942  0,003  Transcription factor NF kappa B inhibitor
0,942  0,004  Antineoplastic (colorectal cancer)
0,940  0,004  Antineoplastic (colon cancer)
0,938  0,002  Antimitotic
0,931  0,003  Antineoplastic (renal cancer)
0,923  0,004  Antineoplastic (non-small cell lung cancer)
0,914  0,004  Antineoplastic (breast cancer)
0,910  0,004  Prostate cancer treatment
0,886  0,005  Antineoplastic (lung cancer)
0,870  0,004  Respiratory analeptic
0,856  0,004  Analeptic
0,850  0,003  P-glycoprotein inhibitor
0,821  0,004  Tubulin antagonist
0,819  0,004  Antineoplastic (lymphocytic leukemia)
0,771  0,012  CYP3A4 substrate
0,758  0,009  CYP2C9 substrate
0,754  0,005  Antineoplastic (cervical cancer)
0,719  0,005  NOS3 expression inhibitor
0,718  0,005  Antineoplastic (brain cancer)
0,716  0,013  TNF expression inhibitor
0,701  0,005  Antineoplastic (carcinoma)
0,720  0,027  Antiinflammatory
0,686  0,007  Proliferative diseases treatment
0,666  0,007  Nitric oxide antagonist
0,645  0,005  Antineoplastic (lymphoma)
0,633  0,009  Cytotoxic
0,596  0,012  Cytostatic
0,556  0,008  Antineoplastic enhancer
0,518  0,006  Antineoplastic (squamous cell carcinoma)
0,515  0,009  ICAM1 expression inhibitor
0,505  0,013  Antineoplastic (glioblastoma multiforme)
0,489  0,020  Antineoplastic (glioma)
0,465  0,036  Angiogenesis inhibitor
0,440  0,017  Antineoplastic (liver cancer)
0,431  0,017  Antineoplastic (endocrine cancer)
0,458  0,045  Immunosuppressant
0,385  0,000  Microtubule stabilization
0,457  0,076  Antineoplastic (solid tumors)
0,402  0,027  Radiosensitizer
0,351  0,003  Actinic keratosis treatment
0,378  0,036  Sensitization
0,349  0,019  Contraceptive
0,327  0,001  Microtubule formation inhibitor
0,331  0,016  Lipocortins synthesis antagonist
0,334  0,044  Antineoplastic (small cell lung cancer)
0,345  0,059  AR expression inhibitor
0,325  0,040  Angiogenesis stimulant
0,330  0,058  Antineoplastic (pancreatic cancer)
0,296  0,027  UGT2B7 substrate
0,333  0,067  Antifungal
0,320  0,056  Antineoplastic (osteosarcoma)
0,338  0,086  Antileukemic
0,294  0,043  Chemopreventive
0,267  0,029  Antipruritic, non-allergic
0,260  0,035  Eye irritation, high
0,292  0,072  CYP1A2 substrate
0,227  0,012  Cyclooxygenase 3 inhibitor
0,223  0,013  Alcohol dehydrogenase substrate
0,252  0,043  Hepatoprotectant
0,213  0,008  Transcription factor NF kappa B stimulant
0,228  0,025  Antineoplastic (bone cancer)
0,267  0,065  Antineoplastic (bladder cancer)
0,223  0,029  Toxic, respiratory center
0,239  0,053  UDP-glucuronosyltransferase substrate
0,277  0,092  Caspase 3 stimulant
0,297  0,123  Antipruritic, allergic
0,259  0,092  Cardioprotectant
0,257  0,093  Immunostimulant
0,202  0,042  Antiacne
0,199  0,040  UGT2B9 substrate
0,178  0,020  Antineoplastic alkaloid
0,219  0,063  Carcinogenic
0,258  0,102  CYP2D6 substrate
0,166  0,011  Anabolic
0,161  0,023  Ca2+-transporting ATPase inhibitor
0,163  0,028  Antineoplastic antibiotic
0,181  0,049  Interferon gamma antagonist
0,202  0,071  UGT1A1 substrate
0,180  0,053  Arachidonic acid antagonist
0,189  0,063  UGT1A4 substrate
0,218  0,100  Antineoplastic (sarcoma)
0,173  0,063  Prostate disorders treatment
0,212  0,106  Antioxidant
0,146  0,044  Growth stimulant
0,110  0,023  Na+ K+ transporting ATPase inhibitor
0,113  0,025  Contraceptive male
0,111  0,025  Antiprotozoal activity enhancer
0,157  0,073  Restenosis treatment
0,102  0,019  Glycine receptor agonist
0,086  0,010  Lipocortins synthesis agonist
0,132  0,058  Antineoplastic (uterine cancer)
0,175  0,102  Pneumotoxic
0,143  0,074  Protein kinase stimulant
0,086  0,021  Estrogen agonist
0,068  0,004  Tubulin agonist
0,180  0,117  NOS2 expression inhibitor
0,100  0,040  ATPase (Vacuolar H+) inhibitor
0,131  0,076  Antifungal enhancer
0,138  0,085  Adenylate cyclase stimulant
0,179  0,127  Tumour necrosis factor alpha release inhibitor
0,124  0,078  Antihemorrhagic
0,057  0,013  Parathyroid hormone antagonist
0,083  0,044  Antibiotic
0,155  0,118  Teratogen
0,105  0,068  Skin irritative effect
0,068  0,032  Androgen agonist
0,068  0,036  Nitric oxide donor
0,207  0,179  Sodium/bile acid cotransporter inhibitor
0,056  0,034  Protein 50S ribosomal subunit inhibitor
0,042  0,027  Hypogonadism treatment
0,139  0,126  Embryotoxic
0,188  0,175  Cholesterol antagonist
0,024  0,011  Corticosteroid-like
0,125  0,113  Growth hormone agonist
0,020  0,008  Telomerase stimulant
0,028  0,018  Purinergic P2X agonist
0,093  0,082  UGT2B1 substrate
0,023  0,013  Vitamin D receptor antagonist
0,034  0,024  Estrogen receptor alpha agonist
0,117  0,111  Farnesoid X receptor antagonist
0,073  0,068  Glycine receptor antagonist
0,062  0,058  Hypercalcemia treatment
0,087  0,085  Expectorant

